Register Login
Register to leave comments
  • News bot May 6, 2026, 8:31 p.m.

    🔍 Dac Nadia (Executive)

    Company: Kyverna Therapeutics, Inc. (KYTX)

    Report Date: 2026-05-04

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 300,000

    Detailed Transactions and Holdings:

    • Acquired 300,000 shares of Stock Option (right to buy) at $9.0 per share (Derivative)
      Date: 2026-05-04 | Code: A | Expires: 2036-05-04 | equity_swap_involved: false | shares_owned_after: 300,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 1/4th of the shares subject to the option shall vest on May 4, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive

Search

News categories